| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.9M | -29.2% |
| Cost of Revenue | $569K | -60.4% |
| R&D Expense | $69.1M | +34.3% |
| SG&A Expense | $26.1M | -7.3% |
| Operating Income | -$93.9M | -19.8% |
| Interest Expense | $73K | +55.3% |
| Pre-tax Income | -$94.2M | -24.0% |
| Income Tax | $0 | — |
| Net Income | -$94.1M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $32K | -84.6% |
| Inventory | $152K | -70.4% |
| Current Assets | $15.7M | -79.0% |
| Total Assets | $23.0M | -71.5% |
| Current Liabilities | $21.4M | +29.1% |
| Long-term Debt | $22K | — |
| Total Liabilities | $23.3M | +29.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$77.8M | -27.0% |
| Capital Expenditures | $2.0M | -13.8% |
| Investing Cash Flow | -$596K | +73.9% |
| Financing Cash Flow | $20.6M | -81.8% |
| Free Cash Flow | -$79.8M | -25.6% |
| -23.4% |
| EPS (Basic) | -$2.55 | +30.7% |
| EPS (Diluted) | -$2.55 | +30.7% |
| Stockholders' Equity |
| -$93K |
| -100.1% |